Context Therapeutics Correlations
CNTX Stock | USD 0.77 0 0.26% |
The current 90-days correlation between Context Therapeutics and Acumen Pharmaceuticals is 0.33 (i.e., Weak diversification). The correlation of Context Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Context Therapeutics Correlation With Market
Weak diversification
The correlation between Context Therapeutics and DJI is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Context Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Context |
Moving together with Context Stock
0.69 | DSGN | Design Therapeutics | PairCorr |
0.8 | EYEN | Eyenovia | PairCorr |
0.88 | CGC | Canopy Growth Corp | PairCorr |
0.62 | MRK | Merck Company | PairCorr |
0.65 | INBX | Inhibrx Symbol Change | PairCorr |
0.9 | ISPC | iSpecimen | PairCorr |
0.61 | ITOS | Iteos Therapeutics | PairCorr |
0.71 | LFCR | Lifecore Biomedical | PairCorr |
0.84 | MREO | Mereo BioPharma Group | PairCorr |
0.82 | ANNX | Annexon Earnings Call This Week | PairCorr |
0.79 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
0.68 | BLUE | Bluebird bio Earnings Call This Week | PairCorr |
0.79 | TLRY | Tilray Inc | PairCorr |
0.8 | CLDX | Celldex Therapeutics | PairCorr |
0.87 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.8 | CRVS | Corvus Pharmaceuticals | PairCorr |
Moving against Context Stock
0.4 | OPT | Opthea | PairCorr |
0.83 | NVRO | Nevro Corp | PairCorr |
0.82 | FNA | Paragon 28 | PairCorr |
0.74 | LUCD | Lucid Diagnostics | PairCorr |
0.73 | CPIX | Cumberland Pharmaceuticals | PairCorr |
0.7 | NYXH | Nyxoah | PairCorr |
0.68 | CMRX | Chimerix | PairCorr |
0.53 | CYTH | Cyclo Therapeutics | PairCorr |
0.51 | INMD | InMode | PairCorr |
0.49 | KIDS | Orthopediatrics Corp | PairCorr |
0.49 | LUNG | Pulmonx Corp | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Context Stock performing well and Context Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Context Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
TERN | 2.99 | (0.99) | 0.00 | (1.29) | 0.00 | 4.94 | 19.13 | |||
AMLX | 3.72 | (0.05) | 0.00 | (0.11) | 0.00 | 7.20 | 21.45 | |||
ABOS | 2.97 | (0.69) | 0.00 | (0.63) | 0.00 | 6.57 | 19.77 | |||
INZY | 4.06 | (1.42) | 0.00 | (0.90) | 0.00 | 6.82 | 36.29 | |||
XFOR | 6.40 | (0.54) | 0.00 | (1.69) | 0.00 | 11.67 | 68.45 | |||
SPRO | 2.57 | (0.56) | 0.00 | 3.53 | 0.00 | 4.85 | 21.98 | |||
BOLT | 2.62 | (0.22) | 0.00 | (1.22) | 0.00 | 5.08 | 17.46 | |||
CHRS | 4.02 | (0.81) | 0.00 | 1.65 | 0.00 | 7.48 | 31.16 | |||
GRCL | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
NLTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Context Therapeutics Corporate Management
Alex Esq | Chief Secretary | Profile | |
Martin Lehr | President, CoFounder | Profile | |
Christopher MBA | Senior Operations | Profile | |
Tarek MD | Chief Officer | Profile | |
Elizabeth CPA | Controller | Profile | |
Jennifer MinaiAzary | CFO Treasurer | Profile | |
Claudio MD | Chief Officer | Profile |